Evaluation of SLC22A5 activity modulation in sensitizing glioma cells to the suppression of fatty acid oxidation by CPT1 inhibitors.

2016/23/N/NZ3/02430

Keywords

Descriptors

  • NZ3_6: Neurobiologia komórkowa

Panel

NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology

Host institution

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Barbara Elżbieta Juraszek

Number of co-investigators in the project: 2

Call

PRELUDIUM 12 – announced on 2016-09-15

Amount awarded
100 000 PLN
Project start date
2017-07-12
Project end date
2019-12-11
Project duration
29 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (2)

  1. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.

    Authors:
    Barbara Juraszek, Katarzyna A Nałęcz
    Academic press:
    Molecules (year: 2020, volume: 25, pages: 46045), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules25010014 – link to the publication
  2. Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5

    Authors:
    Barbara Juraszek, Joanna Czarnecka‐Herok, Katarzyna A. Nałęcz
    Academic press:
    Journal of Neurochemistry (year: 2021, volume: Vol156, Issue 5, pages: 642-657), Publisher: Wiley Online Library
    Status:
    Published
    DOI:
    10.1111/jnc.15124 – link to the publication

Articles in post-conference publications (3)

  1. PO-227 Sensitising glioma cells to fatty acid oxidation inhibitor by modulation of SLC22A5 transporter activity.

    Authors:
    Barbara Juraszek, Katarzyna A. Nałęcz
    Conference:
    25th Biennial Congress of the European Association for Cancer Research (year: 2018, pages: A109), Publisher: ESMO Open 2018
    Date:
    conference 30 czerwca - 3 lipca
    Status:
    Published
    DOI:
    link to the publication
  2. Sensitizing glioma cells to fatty acid oxidation inhibitor by inhibition of SLC22A5 transporter activity.

    Authors:
    Barbara Juraszek, Joanna Czarnecka, Katarzyna A. Nałęcz
    Conference:
    44th FEBS Congress (year: 2019, pages: 325-325), Publisher: FEBS OPEN BIO
    Date:
    conference 6-11 lipca
    Status:
    Published
  3. Sensitizing glioma cells to fatty acid oxidation inhibitor by modulation of SLC22A5 carnitine transporter activity.

    Authors:
    Barbara Juraszek, Joanna Czarnecka, Katarzyna A. Nałęcz
    Conference:
    EMBO Workshop: Cellular Signalling and Cancer Therapy (year: 2018, pages: 110-111), Publisher: EMBO
    Date:
    conference 14-18 września
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski